Table 1.
Demographic characteristics of HPV vaccine recipients.a
| Category | Treatment Arm
|
||
|---|---|---|---|
| A (Nb = 74) | B (N = 23) | P-value | |
| Age at vaccination | |||
| Median (years) | 12 | 12 | 0.426c |
| ≥12 years | 43 (58%) | 13 (57%) | 1.000d |
| Race/ethnicitye | |||
| White (non-Hispanic) | 5 (7%) | 2 (9%) | |
| Black (non-Hispanic) | 37 (50%) | 6 (27%) | 0.097d |
| Hispanic | 31 (42%) | 12 (55%) | |
| Gender (M/F) | 32/42 (57%) | 10/13 (57%) | 1.000d |
| CD4 count (cells/μL) | |||
| Median | 710 | 749 | 0.435c |
| <200 | 1 (1%) | 0 (0%) | 0.835c |
| 200–1000 | 56 (76%) | 17 (74%) | |
| >750 | 17 (23%) | 6 (26%) | |
| CD4% | |||
| Median | 35 | 36 | 0.699c |
| HIV RNA (copies/ml) | |||
| Median | 98 | 85 | 0.472d |
| <400 | 9 (12%) | 4 (17%) | 0.450d |
| 400–5000 | 54 (73%) | 16 (70%) | |
| ≥5000 | 11 (15 %) | 3 (13%) | |
| Antiretroviral (ARV) | |||
| No ARV | 1 (1%) | 2 (9%) | 0.006d |
| 1 class of ARV only | 2 (3%) | 4 (17%) | |
| ≥2 classes of ARVs | 71 (96%) | 17 (74%) | |
a
Demographics at time of enrollment in the current long-term follow-up study.
b
N = number of subjects in arms.
c
Wilcoxon test.
d
Fisher’s Exact test.
e
Information unknown for one subject in arm B.